↓ Skip to main content

RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

Overview of attention for article published in Molecular Cancer Therapeutics, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
1 X user
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
113 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
Published in
Molecular Cancer Therapeutics, June 2013
DOI 10.1158/1535-7163.mct-12-0950
Pubmed ID
Authors

Ahrum Min, Seock-Ah Im, Young-Kwang Yoon, Sang-Hyun Song, Hyun-Jin Nam, Hyung-Seok Hur, Hwang-Phill Kim, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Tae-You Kim, Mark J. O'Connor, Woo-Ho Kim, Yung-Jue Bang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
United Kingdom 1 1%
Netherlands 1 1%
Germany 1 1%
Unknown 94 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 17%
Student > Ph. D. Student 16 16%
Student > Bachelor 12 12%
Student > Master 9 9%
Student > Doctoral Student 6 6%
Other 9 9%
Unknown 29 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 23%
Agricultural and Biological Sciences 22 22%
Medicine and Dentistry 18 18%
Chemistry 4 4%
Engineering 2 2%
Other 2 2%
Unknown 27 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2024.
All research outputs
#5,496,406
of 25,837,817 outputs
Outputs from Molecular Cancer Therapeutics
#1,027
of 4,105 outputs
Outputs of similar age
#44,320
of 212,136 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#21
of 55 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,136 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.